| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-68 |
Sentence |
denotes |
Clinical features of patients undergoing hemodialysis with COVID-19. |
| T2 |
69-146 |
Sentence |
denotes |
Hemodialysis patients are susceptible to coronavirus disease 2019 (COVID-19). |
| T3 |
147-319 |
Sentence |
denotes |
The aim of this study was to describe the epidemiological, clinical characteristics, and mortality-related risk factors for those who undergoing hemodialysis with COVID-19. |
| T4 |
320-355 |
Sentence |
denotes |
We conducted a retrospective study. |
| T5 |
356-467 |
Sentence |
denotes |
A total of 49 hemodialysis patients with COVID-19 (Group 1) and 74 uninfected patients (Group 2) were included. |
| T6 |
468-608 |
Sentence |
denotes |
For patients in Group 1, we found the median age was 62 years (36-89 years), 59.3% were male, and the median dialysis vintage was 26 months. |
| T7 |
609-696 |
Sentence |
denotes |
Twenty-eight patients (57%) had three or more comorbidities and two patients (4%) died. |
| T8 |
697-810 |
Sentence |
denotes |
The most common symptoms were fever (32.7%) and dry cough (46.9%), while nine patients (18.4%) were asymptomatic. |
| T9 |
811-1002 |
Sentence |
denotes |
Blood routine tests indicated lymphocytopenia, the proportion of lymphocyte subsets was generally reduced, and chest CT scans showed ground-glass opacity (45.8%) and patchy shadowing (35.4%). |
| T10 |
1003-1168 |
Sentence |
denotes |
However, these findings were not specific to hemodialysis patients with COVID-19, and similar manifestations could be found in patients without SARS-CoV-2 infection. |
| T11 |
1169-1472 |
Sentence |
denotes |
In conclusion, for hemodialysis patients with COVID-19, lymphocytopenia and ground-glass opacities or patchy opacities were common but not specific to them, early active treatment and interventions against nosocomial infection can significantly reduce the mortality and the risk of SARS-CoV-2 infection. |
